Morgan E. Meissner

Metabolic syndrome is associated with poorer sleep in girls with polycystic ovary syndrome and obesity.

Maternal prepregnancy overweight and obesity were found to be associated with lower IQ scores in boys in low-income, multiethnic populations.

High-intensity statin treatment after ischemic stroke or transient ischemic attack is associated with a reduced risk for subsequent cardiovascular events.

Post hoc analysis results of two phase 3 studies suggest that efficacy, safety, and drug survival of tildrakizumab are comparable in patients with psoriasis regardless of metabolic syndrome status.

Findings show that anti-Müllerian hormone (AMH) is a strong predictor for menstrual disturbance due to PCOS and that the risk for menstrual disturbance was increased with the degree of elevation of AMH.

Findings showed that the combination of insulin and pioglitazone lowered all-cause mortality risk, and this combination therapy exerted beneficial effects on noncardiovascular deaths.

Among older individuals with type 2 diabetes, insulin use is least prevalent in those in good health, and discontinuation of insulin treatment is most likely in healthier patients.

Frequent or persistent vasomotor symptoms during the menopause transition are associated with increased risk for later cardiovascular disease events.

Higher estradiol doses had significant benefits for cardiovascular risk factors in early postmenopausal women, but these effects were attenuated in late postmenopausal women.

The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.

Researchers examined sex differences in clinical presentation and patient outcomes in ACTH-dependent Cushing syndrome.

Exposure to lead is associated with decreased bone mineral density at the femur and spine and increased risk for fracture.

Use of dipeptidyl peptidase-4 inhibitors is associated with an increased risk for pancreatitis and pancreatic cancer in patients with newly diagnosed type 2 diabetes.

Real-world usage of an implantable continuous glucose monitoring system shows promise for improved glycemic control, sensor accuracy, and safety.

Older pubertal age was associated with lower BMD in adolescence and early adulthood, despite some catch-up during puberty.